RASSF1G inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of RASSF1G, a spliced isoform of the RASSF1 (Ras Association Domain Family 1) gene. RASSF1 is part of a larger family of proteins involved in regulating cell cycle progression, apoptosis, and cytoskeletal dynamics, all critical processes for maintaining normal cellular function. RASSF1 isoforms, including RASSF1G, interact with various signaling pathways, particularly those associated with the Ras family of GTPases. These proteins often act as scaffolds or mediators in pathways that govern cell growth, death, and differentiation. RASSF1G, as an isoform, may play specific roles in these processes, distinct from other RASSF1 variants. Inhibitors of RASSF1G work by interfering with its ability to participate in protein-protein interactions or modulate signaling pathways, effectively disrupting its regulatory functions in cellular signaling.
The inhibition of RASSF1G can lead to changes in the cellular processes it controls, particularly in pathways related to apoptosis, cell division, and cytoskeletal organization. By blocking RASSF1G's interactions with key signaling proteins, these inhibitors prevent the proper regulation of cellular responses to growth signals, stress, and other stimuli. Researchers utilize RASSF1G inhibitors to study the precise role this isoform plays within the broader RASSF1 family and to explore how it contributes to cellular homeostasis and signaling networks. These inhibitors are valuable tools for dissecting the functional differences between RASSF1 isoforms and understanding how alternative splicing leads to the specialization of functions within this protein family. Additionally, RASSF1G inhibitors provide insight into the broader regulatory mechanisms of Ras-associated signaling pathways, offering a deeper understanding of how these networks influence cell cycle control, apoptosis, and cytoskeletal rearrangement. Through the study of these inhibitors, researchers gain critical insights into the molecular underpinnings of cellular signaling and regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May demethylate the RASSF1G promoter, resulting in a decrease in gene transcription levels. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Could specifically target DNA methyltransferases, leading to a drop in the methylation status of RASSF1G and subsequent downregulation of its expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Might comprehensively repress RASSF1G transcription by altering histone acetylation patterns at the gene locus. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Could tightly compact chromatin surrounding RASSF1G, leading to significant transcriptional repression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
May preferentially target histone deacetylase activity, leading to a condensed chromatin state at the RASSF1G gene and a reduction in its expression. | ||||||
Hydralazine-15N4 Hydrochloride | 304-20-1 (unlabeled) | sc-490605 | 1 mg | $480.00 | ||
Could decrease the methylation of cytosine residues at the RASSF1G gene, potentially leading to downregulation of its expression. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
Might lead to the reactivation of RASSF1G suppressor functions by decreasing promoter methylation. | ||||||
Phenethyl isothiocyanate | 2257-09-2 | sc-205801 sc-205801A | 5 g 10 g | $104.00 $183.00 | 2 | |
Could disrupt the RASSF1G gene expression by altering the specific methylation pattern of its gene promoter. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Might interfere with the transcriptional machinery binding to RASSF1G, leading to decreased gene expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
May lead to the remodeling of the epigenetic landscape at the RASSF1G locus, resulting in its transcriptional downregulation. | ||||||